 |
Market Cap | 105.92M | EPS (ttm) | 0.92 |
P/E | 12.50 | EPS this Y | 13.74% |
Forward P/E | 9.70 | EPS next Y | 14.49% |
PEG | 0.59 | EPS past 5Y | 25.50% |
P/S | 1.64 | EPS next 5Y | 21.20% |
P/B | 2.93 | EPS Q/Q | 49.27% |
Dividend | - | Sales Q/Q | 12.89% |
Insider Own | 13.48% | Inst Own | 60.93% |
Insider Trans | 0.24% | Inst Trans | 1.12% |
Short Float | 0.19% | Earnings | Mar 27/b |
Analyst Recom | 1.00 | Target Price | 20.50 |
Avg Volume | 15.84K | 52W Range | 11.72 - 17.75 |
|
|
|
FitLife Brands, Inc. engages in the provision of nutritional supplements for health conscious consumers. Its brands include NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Maritime Naturals and MusclePharm. The company was founded by Scott D. Landow on July 26, 2005 and is headquartered in Omaha, NE. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lingenbrink Matthew | Director | Mar 31 '25 | Buy | 12.17 | 2,800 | 34,089 | 2,800 | Apr 02 08:01 AM | Dayton Judd | CHIEF EXECUTIVE OFFICER | Mar 31 '25 | Option Exercise | 2.62 | 144,000 | 377,280 | 1,031,226 | Apr 02 08:00 AM | Ordal Todd | Director | Jan 15 '25 | Buy | 30.37 | 150 | 4,556 | 31,094 | Jan 16 06:12 PM | Dayton Judd | CHIEF EXECUTIVE OFFICER | Dec 30 '24 | Option Exercise | 0.70 | 6,200 | 4,340 | 443,613 | Jan 02 04:30 PM | Ryan Patrick John Phillip | CHIEF RETAIL OFFICER | Jun 03 '24 | Sale | 32.29 | 6,544 | 211,336 | 0 | Jun 04 06:03 PM |
|
|
 |
 |
Market Cap | 5.03M | EPS (ttm) | -7.40 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.08 | EPS next 5Y | - |
P/B | 0.31 | EPS Q/Q | -612.98% |
Dividend | - | Sales Q/Q | -8.07% |
Insider Own | 45.99% | Inst Own | 11.46% |
Insider Trans | 382.39% | Inst Trans | -2.89% |
Short Float | 13.73% | Earnings | - |
Analyst Recom | 3.00 | Target Price | 24.00 |
Avg Volume | 1.37M | 52W Range | 0.99 - 4.01 |
|
|
|
Patriot National Bancorp, Inc. operates as a bank holding company. The firm offers consumer and commercial deposit accounts, such as checking, interest-bearing negotiable order of withdrawal, money market, savings, prepaid deposit, online national money market, individual retirement accounts, and health savings accounts, as well as certificate of deposit account registry services. Its loan portfolio consists of commercial real estate, commercial business, SBA, construction, purchased residential real estate, and various consumer loans. The company also offers automated clearing house transfers, lockbox, Internet banking, bill payment, remote deposit capture, debit cards, money orders, traveler's checks, and automatic teller machine services. The company was founded in 1999 and is headquartered in Stamford, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sugarman Steven | President | Mar 20 '25 | Buy | 0.75 | 7,019,978 | 5,264,984 | 7,019,978 | Apr 01 09:53 PM |
|
|
 |
 |
Market Cap | 59.16M | EPS (ttm) | -0.13 |
P/E | - | EPS this Y | -192.31% |
Forward P/E | - | EPS next Y | 44.74% |
PEG | - | EPS past 5Y | 53.15% |
P/S | 3.28 | EPS next 5Y | - |
P/B | 5.55 | EPS Q/Q | -270.27% |
Dividend | - | Sales Q/Q | 2.08% |
Insider Own | 38.74% | Inst Own | 4.29% |
Insider Trans | 0.40% | Inst Trans | -0.32% |
Short Float | 0.19% | Earnings | Mar 24/a |
Analyst Recom | 1.00 | Target Price | 17.50 |
Avg Volume | 6.12K | 52W Range | 5.85 - 16.50 |
|
|
|
Intellinetics, Inc. is a holding company, which engages in the provision of document services and software solutions to private and public sectors. It operates through the Document Management and Document Conversion segments. The Document Management segment allows customers to capture and manage all documents across operations. The Document Conversion segment assists clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Guttilla John C | Director | Mar 28 '25 | Buy | 12.00 | 3,000 | 36,000 | 24,905 | Apr 01 08:07 PM | Guttilla John C | Director | Dec 05 '24 | Buy | 14.50 | 3,500 | 50,750 | 21,905 | Dec 09 04:00 PM | TAGLICH MICHAEL N | Director | Aug 19 '24 | Buy | 9.00 | 951 | 8,555 | 770,382 | Aug 30 09:35 PM | Guttilla John C | Director | May 29 '24 | Buy | 6.60 | 10,000 | 66,000 | 18,405 | May 31 02:12 PM |
|
|
|  |
 |
Market Cap | 815.37M | EPS (ttm) | -0.37 |
P/E | - | EPS this Y | 201.29% |
Forward P/E | 15.87 | EPS next Y | 132.00% |
PEG | - | EPS past 5Y | -0.52% |
P/S | 0.13 | EPS next 5Y | - |
P/B | 0.73 | EPS Q/Q | 40.36% |
Dividend | - | Sales Q/Q | -7.31% |
Insider Own | 51.46% | Inst Own | 58.65% |
Insider Trans | 1.12% | Inst Trans | 7.25% |
Short Float | 21.01% | Earnings | Mar 26/a |
Analyst Recom | 2.77 | Target Price | 3.57 |
Avg Volume | 4.53M | 52W Range | 1.41 - 6.29 |
|
|
|
Petco Health & Wellness Company, Inc. engages in the provision of pet health and wellness services. It operates across the U.S., Mexico and Puerto Rico, including a growing network, store veterinary hospitals, and offer a complete online resource for pet health and wellness. The firm offers grooming, as well as in-store and online training. The company was founded in 1965 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Anderson Joel D | Chief Executive Officer | Mar 31 '25 | Buy | 3.03 | 849,541 | 2,574,109 | 853,304 | Apr 01 07:14 PM | Anderson Joel D | Chief Executive Officer | Mar 28 '25 | Buy | 2.91 | 736,547 | 2,143,352 | 736,547 | Apr 01 07:14 PM | Zavada John | Former Officer | Dec 10 '24 | Proposed Sale | 4.65 | 58,916 | 274,237 | | Dec 10 01:35 PM | Tichy Justin | Former Officer | Aug 22 '24 | Proposed Sale | 2.75 | 20,743 | 57,063 | | Aug 22 04:54 PM | Tichy Justin | Former Officer | Aug 07 '24 | Proposed Sale | 2.60 | 38,611 | 100,390 | | Aug 07 04:03 PM |
|
|
 |
 |
Market Cap | 795.36M | EPS (ttm) | 5.76 |
P/E | 13.06 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 1.51 | EPS next 5Y | - |
P/B | 2.71 | EPS Q/Q | 83.41% |
Dividend | 8.98% | Sales Q/Q | -1.46% |
Insider Own | 39.84% | Inst Own | 5.56% |
Insider Trans | 5.17% | Inst Trans | -1.75% |
Short Float | 1.09% | Earnings | Feb 18/a |
Analyst Recom | 2.00 | Target Price | 95.00 |
Avg Volume | 28.00K | 52W Range | 62.94 - 88.94 |
|
|
|
CVR Partners LP is a holding company, which engages in the nitrogen fertilizer business. Its products include ammonia and urea ammonium nitrate fertilizers. The company was founded on June 1, 2007 and is headquartered in Sugar Land, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ICAHN CARL C | 10% Owner | Mar 31 '25 | Buy | 74.79 | 2,819 | 210,833 | 207,155 | Apr 01 07:12 PM | ICAHN CARL C | 10% Owner | Mar 28 '25 | Buy | 74.96 | 2,640 | 197,894 | 204,336 | Apr 01 07:12 PM | ICAHN CARL C | 10% Owner | Apr 01 '25 | Buy | 74.69 | 31 | 2,315 | 207,186 | Apr 01 07:12 PM | ICAHN CARL C | 10% Owner | Mar 25 '25 | Buy | 75.00 | 1,058 | 79,350 | 201,516 | Mar 27 05:45 PM | ICAHN CARL C | 10% Owner | Mar 26 '25 | Buy | 75.00 | 180 | 13,500 | 201,696 | Mar 27 05:45 PM |
|
|
|  |
 |
Market Cap | 58.66M | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | 5.81% |
Forward P/E | - | EPS next Y | -11.11% |
PEG | - | EPS past 5Y | 42.59% |
P/S | - | EPS next 5Y | -4.45% |
P/B | 3.33 | EPS Q/Q | 10.75% |
Dividend | - | Sales Q/Q | - |
Insider Own | 49.02% | Inst Own | 8.40% |
Insider Trans | 15.86% | Inst Trans | -11.21% |
Short Float | 0.94% | Earnings | Mar 31/b |
Analyst Recom | 1.00 | Target Price | 4.00 |
Avg Volume | 94.56K | 52W Range | 1.00 - 2.22 |
|
|
|
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Dwyer Donald | Chief Business Officer | Apr 01 '25 | Buy | 1.02 | 4,000 | 4,100 | 55,000 | Apr 01 07:00 PM | Dwyer Donald | Chief Business Officer | Feb 28 '25 | Buy | 1.11 | 1,000 | 1,110 | 51,000 | Mar 03 07:23 PM | Williams Gregg | Director | Nov 08 '24 | Buy | 1.26 | 3,968,253 | 4,999,999 | 4,695,861 | Nov 13 08:46 AM | Dwyer Donald | Chief Business Officer | Oct 01 '24 | Buy | 1.14 | 1,000 | 1,140 | 48,500 | Oct 03 06:10 PM | Dwyer Donald | Chief Business Officer | Oct 02 '24 | Buy | 1.13 | 1,000 | 1,130 | 49,500 | Oct 03 06:10 PM |
|
|
 |
 |
Market Cap | 75.43M | EPS (ttm) | -0.63 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.34 | EPS next 5Y | - |
P/B | 0.59 | EPS Q/Q | -190.08% |
Dividend | - | Sales Q/Q | -4.19% |
Insider Own | 81.66% | Inst Own | 5.13% |
Insider Trans | 0.02% | Inst Trans | 7.16% |
Short Float | 0.40% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.12K | 52W Range | 7.77 - 14.69 |
|
|
|
Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bridgford Baron | President, BFI | Mar 31 '25 | Buy | 8.15 | 100 | 815 | 3,600 | Apr 01 06:55 PM | Bridgford Richard Eugene | V.P. Ind. Relations & Safety | Apr 01 '25 | Buy | 8.02 | 50 | 401 | 2,850 | Apr 01 05:18 PM | Bridgford Allan Jr. | Consultant | Mar 31 '25 | Buy | 8.34 | 300 | 2,502 | 45,000 | Apr 01 05:16 PM | Bridgford Allan Jr. | Consultant | Mar 28 '25 | Buy | 8.34 | 100 | 834 | 44,700 | Apr 01 05:16 PM | Bridgford Richard Eugene | V.P. Ind. Relations & Safety | Mar 28 '25 | Buy | 8.36 | 100 | 836 | 2,800 | Mar 28 06:56 PM |
|
|
|  |
 |
Market Cap | 145.15M | EPS (ttm) | -1.21 |
P/E | - | EPS this Y | -5.33% |
Forward P/E | - | EPS next Y | -15.55% |
PEG | - | EPS past 5Y | -9.86% |
P/S | 100.10 | EPS next 5Y | -9.76% |
P/B | 0.48 | EPS Q/Q | -54.00% |
Dividend | - | Sales Q/Q | -89.29% |
Insider Own | 27.12% | Inst Own | 68.17% |
Insider Trans | 1.12% | Inst Trans | -2.32% |
Short Float | 11.01% | Earnings | Mar 26/a |
Analyst Recom | 1.14 | Target Price | 15.18 |
Avg Volume | 786.33K | 52W Range | 1.90 - 19.05 |
|
|
|
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Spoor Johan M. | Chief Executive Officer | Mar 28 '25 | Buy | 2.24 | 22,026 | 49,384 | 59,383 | Apr 01 06:44 PM | Spoor Johan M. | Chief Executive Officer | Mar 28 '25 | Buy | 2.21 | 4,650 | 10,288 | 4,650 | Apr 01 06:44 PM | Williamson Robert F III | Director | Mar 31 '25 | Buy | 2.14 | 38,145 | 81,775 | 108,982 | Apr 01 05:04 PM | Williamson Robert F III | Director | Mar 28 '25 | Buy | 2.27 | 22,192 | 50,376 | 70,837 | Apr 01 05:04 PM | Graham Juan | Chief Financial Officer | Mar 28 '25 | Buy | 2.25 | 33,333 | 74,946 | 35,354 | Apr 01 05:03 PM |
|
|
 |
 |
Market Cap | 1.35B | EPS (ttm) | 10.81 |
P/E | 4.60 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 47.57 | EPS next 5Y | - |
P/B | 0.86 | EPS Q/Q | -79.20% |
Dividend | 0.90% | Sales Q/Q | 5.40% |
Insider Own | 8.39% | Inst Own | 29.90% |
Insider Trans | 0.18% | Inst Trans | - |
Short Float | 0.04% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 26.56K | 52W Range | 41.01 - 53.62 |
|
|
|
General American Investors Company, Inc. is a publicly owned investment manager. The firm invests in the public equity markets of United States. It invests in growth stocks of companies. It makes investments in Information Technology, Financials, Consumer Staples, Consumer Discretionary, Retailing, Communication Services, Industrials, Health Care, Energy and Materials. The firm employs fundamental analysis with a bottom-up stock picking approach to make its investments. It conducts in-house research to make its investments. General American Investors Company, Inc. was founded in 1927 and is based in New York, New York. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ALTSCHUL ARTHUR G JR | Director | Apr 01 '25 | Sale | 24.83 | 2,000 | 49,656 | 24,400 | Apr 02 03:56 PM | TRUST FBO ALTSCHUL ARTHUR G UW | Trustee is a director | Apr 01 '25 | Sale | 24.83 | 2,000 | 49,656 | 0 | Apr 02 03:45 PM | DAVIDSON SPENCER | Chairman | Apr 01 '25 | Sale | 24.83 | 11,199 | 278,047 | 22,400 | Apr 01 06:57 PM | Priest Jeffrey W | President & CEO | Apr 01 '25 | Buy | 24.75 | 1,735 | 42,941 | 17,127 | Apr 01 06:32 PM | Majmudar Anang K. | Senior Vice-President | Mar 10 '25 | Buy | 24.68 | 950 | 23,446 | 7,250 | Mar 10 04:52 PM |
|
|
 |
 |
Market Cap | 17.73M | EPS (ttm) | -0.91 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -26.51% |
P/S | 0.83 | EPS next 5Y | - |
P/B | 19.53 | EPS Q/Q | -299.48% |
Dividend | - | Sales Q/Q | -8.39% |
Insider Own | 42.58% | Inst Own | 1.93% |
Insider Trans | 6.87% | Inst Trans | 0.28% |
Short Float | 0.95% | Earnings | Feb 14/b |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 195.31K | 52W Range | 0.66 - 3.43 |
|
|
Apr-01-25 08:31AM
|
Perfect Moment Announces $6.4 Million Series AA Convertible Preferred Stock Private Placement
(Business Wire) |
Mar-26-25 07:00AM
|
BWT Alpine Formula One Team and Perfect Moment to Launch Capsule Skiwear Collection
(Business Wire) -9.81% |
Mar-25-25 08:40AM
|
Perfect Moment books $12.7M in wholesale preorders for AW 2025 collection
(TipRanks) |
Mar-24-25 08:31AM
|
Perfect Moment Wholesale Bookings up 30% for New Autumn/Winter 2025 Luxury Ski & Outerwear Collection
(Business Wire) +8.85% |
Mar-17-25 08:31AM
|
Perfect Moment and Worlds #1 Scotch Whisky, Johnnie Walker, Host Exclusive Après-Ski Experiences in Hokkaido, Japan, and Deer Valley, Utah
(Business Wire) +8.85% |
Mar-13-25 08:31AM
|
Perfect Moment Appoints Former Timberland V.P. and General Counsel, Kristine Marvin, as General Counsel
(Business Wire) |
Mar-10-25 08:31AM
|
Perfect Moment Plan to Regain Compliance with Continued Listing Standards Accepted by NYSE American
(Business Wire) -5.71% |
Mar-04-25 08:31AM
|
Perfect Moment Makes Key New Production Hires to Support Growth in Luxury Outerwear
(Business Wire) -5.11% |
Feb-28-25 08:31AM
|
Perfect Moment to Attend the 37th Annual ROTH Conference, March 17-18, 2025
(Business Wire) |
Feb-26-25 08:31AM
|
Perfect Moment Co-Founder and Chairman Purchases 51,000 Shares of Company Stock in the Open Market
(Business Wire) |
|
Perfect Moment Ltd. is a holding company, which engages in the development of branded skiwear and lifestyles products. It offers luxury lifestyle brand that combines fashion and technical performance for ranges of skiwear, outerwear, swimwear, and activewear. The company was founded by Thierry Donard in 1984 and is headquartered in London, the United Kingdom. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gottschalk Max | Director | Mar 28 '25 | Buy | 5.80 | 344,797 | 1,999,995 | 344,797 | Apr 01 06:30 PM | Gottschalk Max | Director | Mar 06 '25 | Buy | 1.00 | 9,860 | 9,886 | 45,960 | Mar 10 08:29 PM | Gottschalk Max | Director | Mar 07 '25 | Buy | 1.10 | 3,500 | 3,835 | 331,753 | Mar 10 08:29 PM | Gottschalk Max | Director | Mar 07 '25 | Buy | 1.07 | 1,060 | 1,130 | 47,020 | Mar 10 08:29 PM | Gottschalk Max | Director | Mar 04 '25 | Buy | 0.94 | 9,739 | 9,199 | 27,339 | Mar 06 09:54 PM |
|
|
|